강민용 (성균관대학교 의과대학 삼성서울병원)님 | 한빛사연구자 > 한빛사

성균관대학교 의과대학 삼성서울병원

최종업데이트 2025.03.09.

Tumor-specific but immunosuppressive CD39+CD8+ T cells exhibit double-faceted roles in clear cell renal cell carcinoma
- Cell Rep. Med., September 16 | https://doi.org/10.1016/j.xcrm.2025.102360
- 2025-09
- 생명과학
- 한빛사논문
Paradoxical Effect of Myosteatosis on the Immune Checkpoint Inhibitor Response in Metastatic Renal Cell Carcinoma
- J. Cachexia Sarcopenia Muscle, Apr 2025, 16 (2) | https://doi.org/10.1002/jcsm.13758
- 2025-04
- 바이오·의료융합
- 한빛사논문
CEACAM1 marks highly suppressive intratumoral regulatory T cells for targeted depletion therapy
- Clin. Cancer Res., FEBRUARY 22 2023;CCR-22-1843 | https://doi.org/10.1158/1078-0432.CCR-22-1843
- 2023-02
- 의약학
- 한빛사논문

연구자 ID

저자논문